Stephany Micallef

Stephany Micallef, Ph.D., is a Senior Regulatory Professional at LEO Pharma, focusing on regulatory strategy and development projects since July 2018. Prior experience includes positions such as EU+ Regulatory Lead and Regulatory Affairs Submissions Manager at Aspen Pharma Trading Ltd from November 2016 to July 2018, and Scientific Officer at the Health Products Regulatory Authority (HPRA) from December 2014 to December 2015, specializing in in vitro medical devices. Stephany also served as a Postdoctoral Researcher at Trinity College Dublin, where research involved cell culture optimization and gene analysis, alongside lecturing in biopharmaceuticals. Educational qualifications include a Ph.D. in Molecular Biology and a Master of Science in Pharmaceutical Analysis, both from Trinity College Dublin, and a Bachelor of Pharmacy from the University of Malta. Previous roles include pharmacist at Boots and medical representative at Vivian Corporation Ltd.